Vermillion Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Vermillion Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.8K	Sell	500 -251	-33%	-$14.4K	0.01%	784
2026 Q1	$45.5K	Buy	751 +65	+9%	+$3.79K	0.02%	214
2025 Q4	$37K	Hold	686	–	–	0.02%	224
2025 Q3	$30.9K	Hold	686	–	–	0.01%	712
2025 Q2	$31.8K	Sell	686 -405	-37%	-$19.9K	0.02%	215
2025 Q1	$66.5K	Buy	1,091 +100	+10%	+$5.83K	0.02%	466
2024 Q4	$56.1K	Buy	+991	New	+$55.4K	0.03%	169

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Vermillion Wealth Management's BMY Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q2 2026, selling an estimated $14.4K and leaving 500 shares worth $28.8K. The position accounts for 0.01% of the portfolio, ranked #784.

Vermillion Wealth Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $66.5K in Q1 2025. 1,021 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Vermillion Wealth Management held 500 shares of Bristol-Myers Squibb worth $28.8K as of Q2 2026.
Vermillion Wealth Management sold 251 Bristol-Myers Squibb shares in Q2 2026, an estimated $14.4K.
Bristol-Myers Squibb made up 0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #784 holding.
Vermillion Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Vermillion Wealth Management's Bristol-Myers Squibb position peaked at $66.5K in Q1 2025.
1,021 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.